Top Markets
#1 Black Phoenix Black Phoenix +354.75%
#2 Akedo Akedo +92.63%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +59.96%
#5 Acurast Acurast +37.34%
#6 OpenEden OpenEden +35.98%
#7 BasedHype BasedHype +27.14%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.45%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +20.43%
Coin of the day
Black Phoenix Black Phoenix
Setări
Limbă
ROMâNă
Monedă
USD
Temă
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc.

CJJD
Rang în acțiuni #40595
China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as... China Jo-Jo Drugstores, Inc., along with its subsidiary entities, functions as a prominent retailer and distributor of a wide array of pharmaceutical and healthcare products across the People's Republic of China. Its operations are structured into four distinct segments: retail pharmacies, an online drugstore, wholesale drug distribution, and the cultivation of medicinal herbs. The company's brick-and-mortar stores supply customers with diverse pharmaceutical items, including both prescription and over-the-counter medications, nutritional supplements, traditional Chinese remedies, personal and family care products, and medical devices. Beyond these, they also stock everyday convenience goods such as consumables, seasonal items, and promotional merchandise. To further enhance customer service, these locations feature licensed practitioners of both Western and Traditional Chinese Medicine, available at scheduled times for consultations, examinations, and the treatment of common ailments. Additionally, China Jo-Jo Drugstores operates an internet-based pharmacy, marketing over-the-counter medications and health supplements directly to consumers, as well as leveraging third-party e-commerce platforms for sales. The enterprise also engages in the wholesale supply of third-party pharmaceutical goods, primarily to trading companies, and manages the cultivation and distribution of herbs utilized in Traditional Chinese Medicine. As of March 31, 2021, the company maintained a network of 109 retail pharmacies operating under the 'Jiuzhou Grand Pharmacy' brand, supplemented by four other drugstores. Founded in 2003, the firm's corporate headquarters are situated in Hangzhou, People's Republic of China.
Preț acțiune
$1.05
Ultima sincronizare: 2025-03-31
Capitalizare de piață
$114.95K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
CN
Tranzacționează China Jo-Jo Drugstores, Inc. (CJJD)

Categorie

Healthcare
Venituri pentru China Jo-Jo Drugstores, Inc. (CJJD)
Venituri în Mar 2024 TTM: $154.54M
Conform celor mai recente rapoarte financiare ale China Jo-Jo Drugstores, Inc., venitul actual al companiei (TTM) este $154.54M. În anul 2023, compania a avut un venit de $148.81M o scădere comparativ cu venitul din anul 2022, care a fost de $164.39M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru China Jo-Jo Drugstores, Inc. din 2007 până în 2026
Venituri la sfârșitul fiecărui an
An Venituri Schimbă
2026 (TTM) $154.54M 0.00%
2024 $154.54M 3.85%
2023 $148.81M -9.48%
2022 $164.39M 23.48%
2021 $133.13M 13.47%
2020 $117.33M 9.09%
2019 $107.55M 11.90%
2018 $96.11M 17.93%
2017 $81.50M -8.50%
2016 $89.07M 15.83%
2015 $76.90M 16.24%
2014 $66.15M -26.08%
2013 $89.50M -5.15%
2012 $94.35M 34.85%
2011 $69.97M 26.81%
2010 $55.17M 0.00%
2008 0.00 0.00%
2007 0.00 0.00%
Venituri pentru companii similare sau concurente
Companie Venituri Diferență de venituri Țara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B 1,540.99%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M 437.60%
US